ArticleGynecologic oncology2018
Significance of venous thromboembolism in women with uterine carcinosarcoma.
Article in Gynecologic oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- Advanced Uterine Carcinosarcoma With Fatal Suspected Pulmonary Embolism in a Resource-Limited Setting: A Rare Case Report.Clinical case reports · 2026Article
- The predictive value of risk assessment models for venous thromboembolism on gynaecological cancer patients.Journal of the colleges of medicine of South Africa · 2025Article
- Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.BMC biotechnology · 2024Article
- An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county.Research and practice in thrombosis and haemostasis · 2024Article
- Uptake of postplacental intrauterine device placement at cesarean delivery.AJOG global reports · 2023Article
- Fatal pulmonary thromboembolism associated with uterine carcinosarcoma.Autopsy & case reports · 2023Article
- The incidence of cancer-associated thrombosis is increasing over time.Blood advances · 2022Article
- Uterine rhabdomyosarcoma complicated by cerebral venous thrombosis and uterine inversion in a young woman: case report and literature review.BMC women's health · 2021Review
- Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.Annals of surgical oncology · 2021Article
- Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.Gynecologic oncology · 2019Article
- Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.Annals of surgical oncology · 2018Article
- Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.Surgical oncology · 2018Article
- Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.Annals of surgical oncology · 2018Article
- Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 20 institutions in 2 countries.
Funding
Abstract
objectiveTo identify risk factors for venous thromboembolism (VTE) and to examine the association of VTE and survival in women with uterine carcinosarcoma.
methodsThis multicenter retrospective study examined 906 women who underwent primary surgical treatment for stage I-IV uterine carcinosarcoma. Time-dependent analyses were performed for cumulative incidence of VTE after surgery on multivariate models.
resultsThere were 72 (7.9%) women who developed VTE after surgery with 1-, 2-, and 5-year cumulative incidences being 5.1%, 7.3%, and 10.2%, respectively. On multivariate analysis, older age (hazard ratio [HR] per year 1.03, P=0.012), non-Asian race (HR 6.28, P<0.001), large body habitus (HR per kg/m
conclusionOur study suggests that VTE represents a surrogate marker of aggressive tumor behavior and diminished patient condition in uterine carcinosarcoma; obese Non-Asian women with large tumors carry a disproportionally high risk of VTE, suggesting that long-term prophylaxis may benefit this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.